MedPath

Bausch Health US, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Alembic Pharmaceuticals Receives US FDA Approval for Diltiazem Hydrochloride Extended-Release Capsules

Alembic Pharmaceuticals has secured US FDA approval for Diltiazem Hydrochloride extended-release capsules (120 mg, 180 mg, 240 mg, 300 mg, and 360 mg).

Alembic Pharmaceuticals Receives USFDA Approval for Diltiazem Hydrochloride Extended-Release Capsules

Alembic Pharmaceuticals secured USFDA approval for Diltiazem Hydrochloride Extended-Release Capsules (120-360 mg).

© Copyright 2025. All Rights Reserved by MedPath